Harvard Bioscience
HBIO
#10472
Rank
NZ$61.03 M
Marketcap
NZ$13.41
Share price
0.38%
Change (1 day)
1,481.22%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -NZ$16.94 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are NZ$85.53 Million. In 2025 the company made an earning of -NZ$97.03 Million a decrease over its 2024 earnings that were of -NZ$19.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$16.94 Million-82.55%
2025 -NZ$97.03 Million391.95%
2024 -NZ$19.73 Million356.38%
2023 -NZ$4.33 Million-72.15%
2022 -NZ$15.52 Million6456.43%
2021 -NZ$0.24 Million-98.08%
2020 -NZ$12.33 Million32.53%
2019 -NZ$9.31 Million-31.01%
2018 -NZ$13.49 Million243.9%
2017 -NZ$3.93 Million-24.66%
2016 -NZ$5.21 Million-14.69%
2015 -NZ$6.11 Million-181.68%
2014 NZ$7.46 M-9.97%
2013 NZ$8.29 M120%
2012 NZ$3.77 M-50.9%
2011 NZ$7.67 M-52.51%
2010 NZ$16.16 M-2.53%
2009 NZ$16.58 M28.26%
2008 NZ$12.93 M-20.05%
2007 NZ$16.17 M13.96%
2006 NZ$14.19 M17.59%
2005 NZ$12.07 M57.37%
2004 NZ$7.67 M-37.31%
2003 NZ$12.23 M208.03%
2002 NZ$3.97 M-168.71%
2001 -NZ$5.79 Million-66.89%
2000 -NZ$17.46 Million